The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Griseofulvin 500 mg film-coated tablets

Brown & Burk IR LimitedPA23148/006/001

Main Information

Trade NameGriseofulvin 500 mg film-coated tablets
Active SubstancesGriseofulvin
Dosage FormFilm-coated tablet
Licence HolderBrown & Burk IR Limited
Licence NumberPA23148/006/001

Group Information

ATC CodeD01BA Antifungals for systemic use
D01BA01 griseofulvin


License statusAuthorised
Licence Issued25/03/2011
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back